| < prev | 1 2 | next > |
Sept. 6, 2012 -- George Chamberlin speaks with Reid Carr, president and CEO of Red Door Interactive, about the growth of his Internet marketing company.
July 26, 2012 -- Arthur Gruen, CEO of EA Health, speaks with George Chamberlin about his efforts to turn his company into a "health care safety net" solution worldwide.
July 26, 2012 -- George Chamberlin and Dave Alberga, CEO of The Active Network, discuss the company's growth and the range of industries it now serves
July 26, 2012 -- Jon Sundt, CEO of Altegris Investments Inc., talks with George Chamberlin about what his company specializes in and what makes it successful.
July 25, 2012 -- Scott Dennis, CEO, and Alex Kunczynski, president of D&K Engineering, talk with George Chamberlin about their company and what it means to be named a winner of the Ernst & Young Entrepreneur of the Year program.
July 25, 2012 -- George Chamberlin speaks with Kelly Grismer, president of accessories company The Wheat Group, about the formation and growth of his family company.
July 19, 2012 -- George Chamberlin sits down with Tom Gildred, CEO of Emerald Textiles, to discuss how his commercial health care linen services company is making a difference in San Diego.
July 19, 2012 -- George Chamberlin speaks with Daniel Sullivan, president of Sullivan Solar Power, about how he started his own firm and how it's grown.
July 18, 2012 -- George Chamberlin speaks with Fred Pierce, president and CEO of Pierce Education Properties LP, about the honor of being named a 2012 winner of the Ernst & Young Entrepreneur Of The Year program, and how his company has grown over the years.
July 18, 2012 -- George Chamberlin and Robert Feeney, president and CEO of Medvantx, discuss Feeney's company, which is a consumer medication management and delivery company, and what it means to be honored by the Ernst & Young Entrepreneur of the Year program.
| < prev | 1 2 | next > |
San Diego’s business news has details of an Urban Land Institute-sponsored session at the University Club and how Illumina is excited about an expected increase in opportunities on genomics sequencing.
 |
 |
 |
 |
 |
